Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C29H29N3O3S |
| Molecular Weight | 499.624 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(CC1=CC=C(OC2=NC=CC=C2C#N)C=C1)NC[C@H](O)COC3=CC=CC=C3C4=CC=CS4
InChI
InChIKey=WIKLBKJBYSBYLL-QHCPKHFHSA-N
InChI=1S/C29H29N3O3S/c1-29(2,17-21-11-13-24(14-12-21)35-28-22(18-30)7-5-15-31-28)32-19-23(33)20-34-26-9-4-3-8-25(26)27-10-6-16-36-27/h3-16,23,32-33H,17,19-20H2,1-2H3/t23-/m0/s1
Lubabegron was initially studied in the Eli Lilly’s lab for potential applications in human health. The drug is a beta-adrenergic agonist that has the effect of increasing the breakdown of fats and increasing energy expenditure in cells. Lubabegron is the first animal drug that was approved to reduce ammonia gas emissions from an animal or its waste. These ammonia gasses can come from many sources and can affect the health of people, animals and the environment.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID20192436
Created by
admin on Mon Mar 31 21:32:27 GMT 2025 , Edited by admin on Mon Mar 31 21:32:27 GMT 2025
|
PRIMARY | |||
|
8501207BZX
Created by
admin on Mon Mar 31 21:32:27 GMT 2025 , Edited by admin on Mon Mar 31 21:32:27 GMT 2025
|
PRIMARY | |||
|
ZZ-87
Created by
admin on Mon Mar 31 21:32:27 GMT 2025 , Edited by admin on Mon Mar 31 21:32:27 GMT 2025
|
PRIMARY | |||
|
C175118
Created by
admin on Mon Mar 31 21:32:27 GMT 2025 , Edited by admin on Mon Mar 31 21:32:27 GMT 2025
|
PRIMARY | |||
|
8501207BZX
Created by
admin on Mon Mar 31 21:32:27 GMT 2025 , Edited by admin on Mon Mar 31 21:32:27 GMT 2025
|
PRIMARY | |||
|
9752
Created by
admin on Mon Mar 31 21:32:27 GMT 2025 , Edited by admin on Mon Mar 31 21:32:27 GMT 2025
|
PRIMARY | |||
|
2360331
Created by
admin on Mon Mar 31 21:32:27 GMT 2025 , Edited by admin on Mon Mar 31 21:32:27 GMT 2025
|
PRIMARY | |||
|
391920-32-4
Created by
admin on Mon Mar 31 21:32:27 GMT 2025 , Edited by admin on Mon Mar 31 21:32:27 GMT 2025
|
PRIMARY | |||
|
60085980
Created by
admin on Mon Mar 31 21:32:27 GMT 2025 , Edited by admin on Mon Mar 31 21:32:27 GMT 2025
|
PRIMARY | |||
|
300000034339
Created by
admin on Mon Mar 31 21:32:27 GMT 2025 , Edited by admin on Mon Mar 31 21:32:27 GMT 2025
|
PRIMARY | |||
|
CHEMBL2364615
Created by
admin on Mon Mar 31 21:32:27 GMT 2025 , Edited by admin on Mon Mar 31 21:32:27 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)